Casdin Capital
Venture capitalNew York · Series A–Series C · 38 people tracked
Investment thesis
Casdin Capital targets large markets in life sciences by identifying promising companies and teams working with molecular information technologies. The firm emphasizes patience, persistence, and strong relationships, applying decades of sector expertise to create value and identify emerging opportunities. The investment approach prioritizes disciplined market selection, quality team evaluation, and avoidance of overconfidence.
Source: firm website, verified Jul 21, 2026.
Team · 38 people
from the firm's websiteWhat they invest in
from 11 of 11 portfolio companiesBiotech ×9AI & Machine Learning ×6Deep Tech ×4Medical Devices ×4Advanced Manufacturing ×2Data & Infrastructure ×2Healthtech ×2Robotics ×2
HQs:United States×9United Kingdom×1
Investments · 11 tracked
founders shown can be your intro pathAsimov collects real-world human activity data at scale from diverse environments to create annotated datasets for training robotics AI models. The company operates both as a data collection platform where individuals earn money for recording their activities and as a service for businesses whose workers perform physical tasks, offering zero-cost labor in exchange for recording data.
Advanced ManufacturingAI & Machine LearningData & InfrastructureRoboticsSan Francisco, US
Lyem Ningthou(Founder)in
Asimov builds a computer-aided design platform for genetic engineering and synthetic biology, enabling genetic designers to program living cells through automated circuit design and computational modeling.
AI & Machine LearningBiotechDeep TechBoston, US
Chris Voigt(Co-founder)Doug Densmore(Co-founder)Alec Nielsen(Co-founder & CEO)Raja Srinivas(Co-founder)
Asimov develops a computer-aided design platform for genetic engineering, enabling designers to program living cells by applying abstraction, standardization, and modeling to biology. The company serves genetic engineers and biotechnology researchers building engineered biological systems.
AI & Machine LearningBiotechDeveloper ToolsBoston, US
Chris Voigt(Co-founder)Doug Densmore(Co-founder)Alec Nielsen(Co-founder & CEO)Raja Srinivas(Co-founder)
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands. The company aims to expand RNAi therapeutics beyond liver targeting to additional cell and tissue types.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)
Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases. The company works with pharmaceutical partners including Novartis, Sarepta, Roche, Spark, and Astellas to advance therapies for patients with genetic disorders.
AI & Machine LearningBiotechWatertown, US
Eric Kelsic(CEO & Cofounder)Sam Sinai(Vice President, Head of ML & Cofounder)Adrian Veres(Chief Scientific Officer & Cofounder)George Church(Scientific Cofounder)
Exo Therapeutics is a small molecule drug discovery company developing therapeutics through its ExoSight platform, which targets exosites—unique binding pockets on enzymes—to address previously undruggable diseases in oncology, inflammation, and other therapeutic areas.
BiotechDeep TechMedical Devices
David Liu, PhD(Founder)Alan Saghatelian, PhD(Co-Founder)David LiuAlan Saghetelian
Fabric Genomics provides an AI-based platform for next-generation sequencing (NGS) analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The platform serves hospitals, clinical laboratories, and academic medical centers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Martin Reese(Co-Founder, President, and CEO)Erwin Frise(Vice President of Technology and Data Science)
Komodo integrates healthcare data across providers, health systems, care settings, and payers to deliver insights on disease incidence, treatment patterns, and health outcomes. The company serves life sciences, healthcare, and payer organizations seeking advanced analytics and AI-powered intelligence.
AI & Machine LearningData & InfrastructureHealthtechSan Francisco, US
Dr. Arif Nathoo(Co-Founder/Co-CEO)Web Sun(Co-Founder/Co-CEO)
Meiogenix develops a plant breeding technology platform that accelerates genetic gain and trait development through targeted recombination, serving crop breeders globally across specialty and field crops.
AgTechBiotech
Multiply Labs builds robotic systems that automate biologics manufacturing for pharmaceutical companies. The platform orchestrates existing laboratory instruments in a closed, sterile environment to increase throughput by up to 100x while reducing costs and contamination risk.
Advanced ManufacturingBiotechDeep TechRoboticsSan Francisco, US
Fred Parietti(Co-Founder & CEO)inAlice Melocchi(Co-Founder & CSO)in
ONI develops the Nanoimager, an automated super-resolution imaging system. The company serves researchers and laboratories in life sciences and microscopy applications.
BiotechDeep TechHardwareMedical DevicesOxford, GB
Board seats · per SEC filings · 2
what is this? ⓘ$39M raise · filed Mar 2023 · via Eli Andrew Casdin, Eli Martin Casdin
$100M raise · filed Apr 2021 · via Eli Casdin
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Casdin Capital invest at?
- Casdin Capital invests at the Series A, Series B, Series C stages.
- What sectors does Casdin Capital focus on?
- Casdin Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is Casdin Capital located?
- Casdin Capital is headquartered in New York, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.